GlassScriptPhysician profile
Dipa M Kodukula
NPI 1730163494
$2,371.07
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $176 · 2021: $163 · 2022: $404 · 2023: $91.93 · 2024: $581 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $586.46 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $345.76 | 2019-2021 | |
| Coopervision INC. | $309.80 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Visioneering Technologies, INC. | $307.65 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $174.44 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $137.27 | 2019 | |
| Bausch & Lomb Americas INC. | $133.56 | 2023-2024 | Infuse |
| Johnson & Johnson Vision Care, INC. | $91.99 | 2019-2023 | Acuvue |
| Oyster Point Pharma, INC. | $64.47 | 2024-2025 | Tyrvaya |
| Abbvie INC. | $56.80 | 2022-2023 | |
| Apellis Pharmaceuticals, INC. | $27.47 | 2024 | Syfovre |
| Rxsight INC | $25.67 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Allergan, INC. | $25.40 | 2021 | |
| Harrow Eye, LLC | $21.63 | 2024 | Vevye |
| Optos, INC. | $19.86 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $16.59 | 2021 | |
| Kala Pharmaceuticals, INC. | $14.14 | 2021 | |
| Alcon Vision LLC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipa Kodukula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.